Logo image of 1BDX.MI

BECTON DICKINSON AND CO (1BDX.MI) Stock Price, Forecast & Analysis

Europe - BIT:1BDX - US0758871091 - Common Stock

156.7 EUR
-8.05 (-4.89%)
Last: 10/30/2025, 7:00:00 PM

1BDX.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap44.91B
Revenue(TTM)21.39B
Net Income(TTM)1.61B
Shares286.63M
Float284.96M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend3.25
Dividend Yield2.25%
EPS(TTM)12.39
PE12.65
Fwd PE12.02
Earnings (Next)11-06 2025-11-06/amc
IPO1963-09-25
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


1BDX.MI short term performance overview.The bars show the price performance of 1BDX.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

1BDX.MI long term performance overview.The bars show the price performance of 1BDX.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1BDX.MI is 156.7 EUR.

BECTON DICKINSON AND CO / 1BDX Daily stock chart

1BDX.MI Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 24.64 185.71B
IUI1.DE INTUITIVE SURGICAL INC 62.05 166.37B
1ISRG.MI INTUITIVE SURGICAL INC 61.68 165.38B
BSX.DE BOSTON SCIENTIFIC CORP 33.67 127.73B
2M6.DE MEDTRONIC PLC 16.2 99.72B
SHL.DE SIEMENS HEALTHINEERS AG 20.47 54.94B
BOX.DE BECTON DICKINSON AND CO 12.31 43.73B
EWL.DE EDWARDS LIFESCIENCES CORP 32.13 42.07B
PHI1.DE KONINKLIJKE PHILIPS NV 16.48 22.85B
PHIA.AS KONINKLIJKE PHILIPS NV 16.97 23.53B
1DXCM.MI DEXCOM INC 32.27 20.50B
DC4.DE DEXCOM INC 32.22 20.47B

About 1BDX.MI

Company Profile

1BDX logo image Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Company Info

BECTON DICKINSON AND CO

One Becton Drive

Franklin Lakes NEW JERSEY US

Employees: 74000

1BDX Company Website

1BDX Investor Relations

Phone: 12018476800

BECTON DICKINSON AND CO / 1BDX.MI FAQ

Can you describe the business of BECTON DICKINSON AND CO?

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


What is the stock price of BECTON DICKINSON AND CO today?

The current stock price of 1BDX.MI is 156.7 EUR. The price decreased by -4.89% in the last trading session.


Does BECTON DICKINSON AND CO pay dividends?

BECTON DICKINSON AND CO (1BDX.MI) has a dividend yield of 2.25%. The yearly dividend amount is currently 3.25.


What is the ChartMill technical and fundamental rating of 1BDX stock?

1BDX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the analyst forecast for 1BDX.MI stock?

18 analysts have analysed 1BDX.MI and the average price target is 188.34 EUR. This implies a price increase of 20.19% is expected in the next year compared to the current price of 156.7.


Should I buy 1BDX stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1BDX.MI.


What is the market capitalization of 1BDX stock?

BECTON DICKINSON AND CO (1BDX.MI) has a market capitalization of 44.91B EUR. This makes 1BDX.MI a Large Cap stock.


1BDX.MI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to 1BDX.MI.


Chartmill TA Rating
Chartmill Setup Rating

1BDX.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1BDX.MI. 1BDX.MI has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1BDX.MI Financial Highlights

Over the last trailing twelve months 1BDX.MI reported a non-GAAP Earnings per Share(EPS) of 12.39. The EPS increased by 11.75% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.51%
ROA 2.93%
ROE 6.3%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%5.14%
Sales Q2Q%10.4%
EPS 1Y (TTM)11.75%
Revenue 1Y (TTM)7.86%

1BDX.MI Forecast & Estimates

18 analysts have analysed 1BDX.MI and the average price target is 188.34 EUR. This implies a price increase of 20.19% is expected in the next year compared to the current price of 156.7.

For the next year, analysts expect an EPS growth of 10.38% and a revenue growth 8.43% for 1BDX.MI


Analysts
Analysts73.33
Price Target188.34 (20.19%)
EPS Next Y10.38%
Revenue Next Year8.43%

1BDX.MI Ownership

Ownership
Inst Owners92.24%
Ins Owners0.57%
Short Float %N/A
Short RatioN/A